Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy



Status:Active, not recruiting
Conditions:Breast Cancer, Cancer, Chronic Pain, Orthopedic
Therapuetic Areas:Musculoskeletal, Oncology, Orthopedics / Podiatry
Healthy:No
Age Range:21 - 99
Updated:4/21/2016
Start Date:August 2013
End Date:May 2016

Use our guide to learn which trials are right for you!

For post-menopausal women diagnosed with hormone-receptor positive breast cancer tumors,
aromatase inhibitors (AIs) are the standard adjuvant hormone treatment to prolong
disease-free survival and time-to-recurrence. Unfortunately, joint pain/stiffness/achiness
(arthralgia) is a common side-effect of AIs. This "proof-of-concept" study explores how an
evidence-based physical activity (PA) program- the Arthritis Foundation's Walk with Ease
(WWE) program- can be adapted for breast cancer survivors on AI therapy to: 1) Help them
maintain or achieve recommended levels of PA, 2) reduce their joint pain/stiffness/achiness,
and 3) thereby enable them to remain on AI therapy as prescribed.


Inclusion Criteria:

- Taking an aromatase inhibitor as adjuvant treatment for State I, II, or II breast
cancer for at least 4 weeks

- Experiencing more than mild joint pain/symptoms

- 21 or older

- have permission from physician to engage in moderate intensity physical activity

Exclusion Criteria:

- Undergoing chemotherapy and/or radiation therapy at any time during the study period

- Scheduled for major surgery during the study period

- Presently engaged in high levels of physical activity on a daily basis

- Less than 21 years of age

- Unable to walk or engage in moderate intensity physical activity
We found this trial at
1
site
Chapel Hill, North Carolina 27599
(919) 962-2211
Univ of North Carolina Carolina’s vibrant people and programs attest to the University’s long-standing place...
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials